Tag Archives: BIO International Convention

GEN’s “Top 10” Session Picks for the 2013 BIO International Convention

John Sterling

As the industry moves forward in 2013, it again faces one of its regular bugaboos—uncertainty. “Where are we headed?” has been a standard phrase among bioindustry observers since the early 1980s. As it turns out, the biopharmaceutical business must once again deal with a number of important issues this year. For example, G. Steven Burrill, CEO of Burrill & Co., points out that the cuts mandated by the U.S. Congress’ sequestration fiscal policy may slow Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Forbes 30 Under 30: Rising Biotech Stars at the 2013 BIO International Convention

Forbes 30 Under 30

For the second year in a row, Forbes magazine published a list of the most awe-inspiring rising stars in science and healthcare – all under the age of 30. A select group of these rising stars will attend the 2013 BIO International Convention and participate in a Keynote Luncheon Tuesday, April 23, with BIO President and CEO Jim Greenwood. Keynotes and evening events are open to Convention Access and Full Convention Access Registrations! Registration discounts Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Convention Veterans Putting the “Super” in Super Sessions

Worldview

Featured in the BIO Buzz Center at last year’s Convention, two of our Super Session participants will once again join us to host a dynamic group of C-level industry thought leaders, sharing their perspectives on the current economic environment and major trends that will impact the future of the global industry. Ernst & Young will present insights from their annual report which looks to measure the industry performance through key metrics such as financial results, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Call for Nominations: BIO International Convention’s Buzz of BIO Contest

Buzz of BIO

The BIO International Convention is all about raising your profile. Make connections, get your story heard, move business forward. One of the more creative and fun ways to accomplish these goals is the Buzz of BIO contest. This is an online voting contest for the industry to cast their pick for this year’s most creative biotech company. Nominate Your Company The contest is open to R&D-intensive companies looking to develop strategic partnerships within the industry. Answer Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Navigating the Rare Disease World

Susan Ruediger

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of big pharmaceutical companies and U.S. legislation favoring development and coverage. This growth promises to improve the health of patients with debilitating and life-threatening disorders. Hoping to further the rare disease dialogue and relationship building opportunities, the 2013 Orphan Disease Forum will provide unique perspective on the orphan drug marketplace, regulatory considerations and much more. Operating within Read More >

Events  |  2 Comments  |  Email This Post
Tags: , , , , , , , ,